Lenovo-Backed Neural Interface Firm Nurochips Raises $420M to Restore Vision for the Blind

May 06, 2026 18:16 CST Updated 18:16

Nanochap

Core Chip Developer in the Biomedical Field

Recently, brain-computer interface enterprisesNanochapAnnouncement CompletedRMB 300 million in strategic financing, byWell-known industrial investment institutionsAffiliated with Lenovo'sLegend CapitalCo-led by, existing shareholdersFengnian CapitalOver-investment,GF XindeAndCaitong CapitalCo-investment。

The funds raised will be mainly used forVisual Brain-Computer InterfaceClinical trial progress and core technology iteration of the product, etc.

Visual Brain-Computer Interface Restores Sight to the Blind

Nanochap, established in 2014, is a technology startup specializing in the research, development, production, and sales of brain-computer interfaces and neuro-bio chips.

The company has releasedRetinal Pathway Brain-Computer Interface E-BCI, Visual Cortex Pathway Brain-Computer Interface V-BCITwo visual reconstruction brain-computer interface products have increased the maximum number of signal acquisition and stimulation channels to 1,280, and their underlying technologies are all self-developed.

As early asIn 2024, itsThe retinal interface product has obtained a type inspection report, and nearly a hundred large animal and primate experiments have been completed.Launch human clinical trials,Visual Cortex Pathway Brain-Computer Interface Product to Enter Prospective Clinical Trials This Year

Nanochap has also built a nearly 2000㎡ GMP-certified clean room with ten-thousand-grade standards.Equipped with a complete independent production line for brain-computer interface implants, core manufacturing equipment and all key processes are independently developed.

—The End—